KZA 0.00% 8.0¢ kazia therapeutics limited

News: KZA Kazia Says Phase II Study Of Paxalisib In Brain Metastases Advances To Expansion Stage In..., page-5

  1. 856 Posts.
    lightbulb Created with Sketch. 356
    Showing signs of efficacy in a $10+ billion market potential, sounds good to me.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.